dobutamin hameln 12.5 mg/ ml
hameln pharma gmbh - dobutaminhydroklorid - konsentrat til infusjonsvæske, oppløsning - 12.5 mg/ ml
scemblix
novartis europharm limited - asciminib hydrochloride - leukemi, myelogen, kronisk, bcr-abl positiv - antineoplastiske midler - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.
efexor depot 150 mg
upjohn eesv - venlafaksinhydroklorid - depotkapsel, hard - 150 mg
efexor depot 75 mg
upjohn eesv - venlafaksinhydroklorid - depotkapsel, hard - 75 mg
venorion 75 mg
orion corporation - espoo - venlafaksinhydroklorid - depotkapsel, hard - 75 mg
venorion 37.5 mg
orion corporation - espoo - venlafaksinhydroklorid - depotkapsel, hard - 37.5 mg
venorion 150 mg
orion corporation - espoo - venlafaksinhydroklorid - depotkapsel, hard - 150 mg
venlafaxin krka 150 mg
krka sverige ab - venlafaksinhydroklorid - depotkapsel, hard - 150 mg
venlafaxin krka 37.5 mg
krka sverige ab - venlafaksinhydroklorid - depotkapsel, hard - 37.5 mg
venlafaxin krka 75 mg
krka sverige ab - venlafaksinhydroklorid - depotkapsel, hard - 75 mg